Serum albumin >= 2 g/dLXx_NEWLINE_xXPARTICIPANTS NOT ON THE HODGKIN LYMPHOMA EXPANSION COHORT: Serum albumin >= 2.8 g/dL, within 2 weeks prior to enrollmentXx_NEWLINE_xXPARTICIPANTS ON THE HODGKIN LYMPHOMA EXPANSION COHORT: Serum albumin: >= 2.8 g/dL, within 2 weeks prior to enrollmentXx_NEWLINE_xXAlbumin >= 2.5 g/dL within 30 days of day 1 of studyXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXPatients with hypersensitivity to albumin are not eligibleXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin >= 2.7 g/dLXx_NEWLINE_xXSerum albumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXWithin 2 weeks prior to registration: Serum albumin >= 2.8 g/dLXx_NEWLINE_xXSerum albumin >= 3.0 g/dL within 90 days prior to Step 1 registrationXx_NEWLINE_xXAlbumin > 3 mg/dlXx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXPatients with solid tumors: serum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin >= 2.8 g/dLXx_NEWLINE_xXSerum albumin < 3 g/dLXx_NEWLINE_xXAlbumin >= 2 g/dlXx_NEWLINE_xXAlbumin >= 3.0 g/dL (within 14 days of treatment initiation)Xx_NEWLINE_xXWithin 14 days of treatment initiation: Albumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin >= 2.8 g/dlXx_NEWLINE_xXAlbumin >= 2.5 mg/dL (up to 14 days before treatment initiation)Xx_NEWLINE_xXSerum albumin > 2.7 g/dLXx_NEWLINE_xXCalcium >= LLN (corrected for serum albumin, if albumin abnormal)Xx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXWithin 10 days of treatment initiation: Albumin >= 2.5 mg/dLXx_NEWLINE_xXSerum albumin ? 2.8 g/dLXx_NEWLINE_xXAlbumin > 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 10 days of treatment initiationXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dL, performed within 14 days of treatment initiationXx_NEWLINE_xXAlbumin >= 2.0 g/dLXx_NEWLINE_xXAlbumin ? 2.0 g/dLXx_NEWLINE_xXCOHORT 1: Albumin > 2.5 mg/dL within 14 days of treatment initiationXx_NEWLINE_xXCOHORT 2: Albumin > 2.5 mg/dL within 14 days of treatment initiationXx_NEWLINE_xXSerum albumin >= 30 g/LXx_NEWLINE_xXAlbumin ?3 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin ?3.0 gm/dL;Xx_NEWLINE_xXSerum albumin >= 2.8 g/dl, within 14 days before the first dose of cabozantinibXx_NEWLINE_xXSerum albumin >= 2.5Xx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 2.8 g/dl within 7 days before the first dose of cabozantinibXx_NEWLINE_xXAlbumin > 3.0 g/dL.Xx_NEWLINE_xXAlbumin > 2.5 mg/dLXx_NEWLINE_xXAlbumin > 2.5 mg/dLXx_NEWLINE_xXAlbumin > 3 g/dLXx_NEWLINE_xXWithin 10 (except as noted) days of planned treatment initiation: Albumin >= 2.5 mg/dL (may be within 28 days)Xx_NEWLINE_xXDose Escalation: Must have a serum albumin during Screening of >= 3.2 g/ dL.Xx_NEWLINE_xXAlbumin >= 2.5 mg/dlXx_NEWLINE_xXAlbumin >= 2.5 mg/dL.Xx_NEWLINE_xXSerum albumin ?3.5 g/dL (?35 grams per liter (g/L));Xx_NEWLINE_xXSerum albumin < 3.0 g/dL unless prothrombin time is within the normal rangeXx_NEWLINE_xXAlbumin >= 2.8 g/dLXx_NEWLINE_xXObtained =< 2 weeks prior to registration: Albumin >= 3.0 g/dLXx_NEWLINE_xXSerum albumin >= 3.0 g/dL performed within 30 days prior to the date of registrationXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 10 days of treatment initiationXx_NEWLINE_xXWithin 14 days of treatment registration: Albumin >= 2.5 mg/dLXx_NEWLINE_xXSerum albumin < 2.9 g/dL.Xx_NEWLINE_xXSerum albumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXSerum albumin ? 3.0 g/dLXx_NEWLINE_xXDocumented within 14 days of registration: Albumin >= 3 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSubjects with serum calcium (corrected for albumin) ? 12 mg/dLXx_NEWLINE_xXSerum albumin ? 3 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 14 days of treatment initiationXx_NEWLINE_xXAlbumin >= 2.5 mg/dL within 14 days of treatment initiationXx_NEWLINE_xXAlbumin >= 2 g/dLXx_NEWLINE_xXAlbumin >= 2.4 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL (performed within 28 days of treatment initiation)Xx_NEWLINE_xXSerum albumin ?2.5 g/dL.Xx_NEWLINE_xXAlbumin >= 2 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 28 days of study registrationXx_NEWLINE_xXAlbumin ? 3.0 g/dL.Xx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin > 25 g/LXx_NEWLINE_xXAlbumin >= 2 g/dlXx_NEWLINE_xXSerum albumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin >= 3 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum Albumin < 2.5 g/dLXx_NEWLINE_xXWithin 14 days of randomization: Albumin > 30 g/LXx_NEWLINE_xXSerum albumin >= 2 g/dL.Xx_NEWLINE_xXSerum albumin >= 2.8 g/dL.Xx_NEWLINE_xXAlbumin >= 2.5 g/dlXx_NEWLINE_xXAlbumin > 2.8 g/dL.Xx_NEWLINE_xXAlbumin ? 3.0 g/dlXx_NEWLINE_xXSerum albumin >= LLN or 3 g/dlXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 28 days of treatment initiationXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, should be performed within 10 days of treatment initiationXx_NEWLINE_xXAlbumin at least 2.8 g/dLXx_NEWLINE_xXMust have serum albumin > 2.5 mg/dL without intravenous supplementationXx_NEWLINE_xXWithin 28 days prior to treatment start: Albumin >= 3.0 g/dLXx_NEWLINE_xXAlbumin >= 3.0.Xx_NEWLINE_xXSerum albumin ? 2.0 g/dLXx_NEWLINE_xXAlbumin >= 3.2 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 10 days of treatmentXx_NEWLINE_xXAlbumin > 2.5 mg/dL within 21 days of treatment initiationXx_NEWLINE_xXDecreased serum albumin < 30 g/L (< 3 g/dL)Xx_NEWLINE_xXSerum albumin concentration ?30 g/LXx_NEWLINE_xXAlbumin >= 2.5 mg/dL within 21 days of treatment initiationXx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXShould be performed within 30 days of treatment initiation: albumin ? 2.5 mg/dLXx_NEWLINE_xXWithin 28 days of cycle 1 day 1: Albumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL (performed within 10 days of treatment initiation)Xx_NEWLINE_xXWithin 5 days prior to the start of study treatment: Albumin: >= 2.5 mg/dL.Xx_NEWLINE_xXAlbumin > 2.7 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dlXx_NEWLINE_xXSerum albumin ?2.5 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 2 gm/dLXx_NEWLINE_xXAlbumin >= 3 g/dL, within 14 days of registration and within 7 days of the start of treatmentXx_NEWLINE_xXAlbumin >= 2.8 g/dLXx_NEWLINE_xXAlbumin >= 3.0 g/dLXx_NEWLINE_xXObtained within 28 days prior to the first dose of cabozantinib: serum albumin >= 2.8 g/dl.Xx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 14 days of treatment initiationXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 28 days of treatment initiationXx_NEWLINE_xXWithin 3 days before the first dose of study drug: albumin > 2.7 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin > 2.5 mg/dL.Xx_NEWLINE_xXTo be performed within 14 days of treatment initiation: albumin ? 2.5 mg/dLXx_NEWLINE_xXAlbumin ? 2.5 mg/dL within 14 days of treatment initiationXx_NEWLINE_xXAlbumin > 2.5 mg/dLXx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXWithin 10 days of treatment initiation: Albumin >= 2.5 mg/dL.Xx_NEWLINE_xXWithin 10 days of treatment initiation: Albumin >= 2.5 mg/dLXx_NEWLINE_xXWithin 14 days of treatment initiation: Albumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 3.5 g/dL, obtained within 7 days prior to first study treatmentXx_NEWLINE_xXPerformed within 10 days of treatment initiation: Albumin >= 2.0 mg/dLXx_NEWLINE_xXSerum albumin >= 3 g/dl.Xx_NEWLINE_xXAlbumin >= 2.5 mg/dL.Xx_NEWLINE_xXObtained =< 14 days prior to registration: Albumin >= 2.5 mg/dLXx_NEWLINE_xXWithin 10 days prior to on-study date: Albumin ? 2.5 mg/dLXx_NEWLINE_xXAlbumin > 3.0 mg/dLXx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXSerum albumin ? 3 g/dLXx_NEWLINE_xXObtained with 21 days of registration: albumin: > 2.8 g/dlXx_NEWLINE_xXWithin 10 days of treatment initiation: Albumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin level ?3 g/dLXx_NEWLINE_xXSerum albumin ?2 g/dL.Xx_NEWLINE_xXWithin 10 days of treatment initiation: Albumin ? 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.0 g/dLXx_NEWLINE_xXAlbumin ? 2.5 mg/dLXx_NEWLINE_xXSerum albumin >= 2.0 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin >= 3.0 mg/dL (performed within 10 days of treatment initiation)Xx_NEWLINE_xXAlbumin >= 3 g/dL.Xx_NEWLINE_xXWithin 7 days (+ 3 day window) of enrollment: Albumin >= 2.5 g/dlXx_NEWLINE_xXWithin 7 days before the first dose of study treatment: Serum albumin >= 2.8 g/dlXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 10 days of treatment initiationXx_NEWLINE_xXAlbumin > 25 g/LXx_NEWLINE_xXSerum albumin =< 3.0 g/dL unless prothrombin time is within the normal rangeXx_NEWLINE_xXSerum albumin < 2.5 g/dLXx_NEWLINE_xXObtained =< 28 days prior to registration: Albumin >= 2.5 mg/dLXx_NEWLINE_xXPerformed within 7 days of treatment initiation: Albumin >= 2.5 mg/dLXx_NEWLINE_xXSerum albumin >= 2.0 g/dLXx_NEWLINE_xXSerum albumin >= 3 g/dlXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 14 days of treatment initiationXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 10 days of treatment initiationXx_NEWLINE_xXWithin 14 days prior to registration: Albumin >= 2.5 g/dLXx_NEWLINE_xXWithin 14 days prior to cycle 1 day 1 of treatment: Serum albumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin >= 2.5 g/dlXx_NEWLINE_xXAlbumin > 2.9 gm/dLXx_NEWLINE_xX(For both cohorts A and B): Serum albumin > 2Xx_NEWLINE_xXAlbumin >= 3.0 g/dL obtained < 4 weeks prior to starting treatmentXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dL within 14 days of registrationXx_NEWLINE_xXAlbumin >= 2.0 g/dLXx_NEWLINE_xXPerformed within 10 days of treatment initiation: Albumin >= 2.5 mg/dLXx_NEWLINE_xXDetermined within 3 weeks of treatment initiation: Albumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL within 14 days of treatment initiationXx_NEWLINE_xXAlbumin ? 2 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin > 2.8 g/dlXx_NEWLINE_xXSerum albumin of > 3.0 g/dLXx_NEWLINE_xXWithin 10 days of treatment initiation: Albumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXWithin 14 days of treatment initiation: Albumin > 2.5 mg/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin > 28 g/LXx_NEWLINE_xXAlbumin > 2.5 g/dL (obtained within 28 days prior to first study treatment)Xx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 14 days of registrationXx_NEWLINE_xXAlbumin > 2.7 g/dLXx_NEWLINE_xXPerformed within 10 days of treatment initiation: Albumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.8 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL (performed within 28 days of registration)Xx_NEWLINE_xXAlbumin >= 2.0 mg/dL performed within 10 days of treatment initiationXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL (within 10-15 days of treatment initiation)Xx_NEWLINE_xXAlbumin >= 2.5 mg/dL within 16 days of treatment initiationXx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXAlbumin >= 3 g/dL performed within 7 days of treatment initiationXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, during screening and on cycle 1, day 1Xx_NEWLINE_xXHas laboratory evidence of hypercalcemia (>= 11mg/dl [in presence of normal albumin]) and/or hyperphosphatemia (>= 5.5)Xx_NEWLINE_xXAlbumin >= 2.5 mg/dL within 14 days of treatment initiationXx_NEWLINE_xXAlbumin ? 3g/dLXx_NEWLINE_xXAlbumin >= 3.3 mg/dL in the absence of dehydration (performed within 10 days of treatment initiation)Xx_NEWLINE_xXAlbumin < 2.5Xx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXWithin 10 days of treatment initiation: Albumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin: > 2.5 mg/dLXx_NEWLINE_xXSerum albumin < 3 g/dLXx_NEWLINE_xXCompleted within 10 days of SBRT treatment initiation: Albumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin > 2.8 g/dL.Xx_NEWLINE_xXSerum albumin; if cirrhosis present: part of Child Pugh requirement; if no cirrhosis: albumin should be >= 2.5 g/dlXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dL within 14 days of treatment initiationXx_NEWLINE_xXSerum albumin >= 2.5 mg/dL without intravenous supplementationXx_NEWLINE_xXMust have serum albumin > 2.5 mg/dL without intravenous supplementationXx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin > 3.0 g/dlXx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXAlbumin > 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 10 days of treatment initiationXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin > 2.5 g/dLXx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXSubjects with serum calcium (corrected for albumin) >= 12 mg/dLXx_NEWLINE_xXPerformed within 14 days of treatment initiation: Albumin >= 3.0 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin > 3.0 gm/dLXx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dL within 7 days prior to enrollmentXx_NEWLINE_xXWithin 3 months of registration: Serum albumin > 3.0 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXARM A COHORT 1: Serum albumin >= 2.5 g/dLXx_NEWLINE_xXARM B COHORT 2: Serum albumin >= 2.5 g/dLXx_NEWLINE_xXARM B COHORT 3: Serum albumin >= 2.5 g/dLXx_NEWLINE_xXARM C COHORT 4: Serum albumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin < 2.0 g/dL or < 20 g/LXx_NEWLINE_xXAny serum albumin is allowed, but >= 3.4 g/dL is strongly encouragedXx_NEWLINE_xXSerum/plasma albumin > 3.0 gm/dLXx_NEWLINE_xXSerum albumin must be greater than or equal to 2 g/dLXx_NEWLINE_xXFor Part A participants: serum albumin >= 2 g/dLXx_NEWLINE_xXFor Part B participants: serum albumin >= 2g/dLXx_NEWLINE_xXSerum albumin >= 3.0g/dLXx_NEWLINE_xXSerum albumin ? 2 g/dL.Xx_NEWLINE_xXAlbumin > 25 g/LXx_NEWLINE_xXWithin 4 days prior to the first dose of cabozantinib: Serum albumin >= 2.8 g/dlXx_NEWLINE_xXAlbumin >= 2.8 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin < 2.0 g/dL or < 20 g/LXx_NEWLINE_xXAlbumin > 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin ? 2.8 g/dLXx_NEWLINE_xXSerum albumin < 2.8 g/dL.Xx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin > 2.0 g/dlXx_NEWLINE_xXSerum albumin ?3.0 gm/dL.Xx_NEWLINE_xXSerum albumin >= 2.0 g/dlXx_NEWLINE_xXAlbumin > 2.4 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin > 2.4 g/dLXx_NEWLINE_xXAlbumin >= 2.0 g/dL or >= 20 g/L obtained =< 2 weeks prior to enrollmentXx_NEWLINE_xXSerum albumin >= 3 g/dlXx_NEWLINE_xXAlbumin > 2 g/dLXx_NEWLINE_xXSerum albumin of >= 3.0 g/dlXx_NEWLINE_xXAlbumin >= 2 g/dlXx_NEWLINE_xXAlbumin < 30 g/L (3.0 g/dL) at screeningXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2 g/dLXx_NEWLINE_xXAlbumin > 2.5 mg/dlXx_NEWLINE_xXAlbumin >= 2g/dLXx_NEWLINE_xXAlbumin > 3.0Xx_NEWLINE_xXLow baseline albumin < 3.5 g/dlXx_NEWLINE_xXSerum albumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin ? 2.5 g/dLXx_NEWLINE_xXAlbumin ? 2.5 mg/dLXx_NEWLINE_xXBaseline serum albumin > 30 g/LXx_NEWLINE_xXSerum albumin ?2 g/dLXx_NEWLINE_xXAlbumin ?2.5mg/dLXx_NEWLINE_xXalbumin ? 2.8 g/dL.Xx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin > 2.7 g/dL (repeat if more than 3 days before the first dose)Xx_NEWLINE_xXHypoalbuminaemia (serum albumin < 30 g/L)Xx_NEWLINE_xXSerum albumin ? 3.0 mg/dL.Xx_NEWLINE_xXAlbumin ? 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 3 g/dlXx_NEWLINE_xXORAL CAVITY SQUAMOUS CELL CARCINOMA COHORT: Serum albumin > 3.0 g/dLXx_NEWLINE_xXHPV-ASSOCIATED OROPHARYNX SQUAMOUS CELL CARCINOMA: Serum albumin > 3.0 g/dLXx_NEWLINE_xXAlbumin ? 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.0 g/dLXx_NEWLINE_xXSerum albumin ? 3.0 g/dLXx_NEWLINE_xXSerum albumin >= 3g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin > 2.7 g/dLXx_NEWLINE_xXWithin 14 days prior to first dose of study drug treatment: Albumin >= 2.5 g/dLXx_NEWLINE_xXRENAL COHORT: Laboratory values as follows within 4 days before the first dose of daratumumab: serum albumin ? 2.8 g/dlXx_NEWLINE_xXBLADDER: Clinical laboratory values at screening: serum albumin ? 2.8g/dlXx_NEWLINE_xXWithin 7 days before the first dose of cabozantinib: Serum albumin >= 2.8 g/dlXx_NEWLINE_xXWithin 10 days of treatment initiation: albumin >= 3 mg/dL. Creatinine clearance should be calculated per institutional standardXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 28 days of treatment initiationXx_NEWLINE_xXWithin 10 days of treatment initiation: Albumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin >= 2.5 g/dLXx_NEWLINE_xXLiver function tests performed within 3 weeks prior to starting study therapy must have albumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin >= 3 g/dlXx_NEWLINE_xXAlbumin >= 2.5 g/dlXx_NEWLINE_xXWithin 7 days prior to study registration: Serum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXWithin 28 days of study registration: Albumin >= 3.0 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXSerum albumin >= 28 g/LXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL (performed within 10 days of treatment initiation)Xx_NEWLINE_xXAlbumin >= 2.5 gm/dlXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin > 2 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXWithin 30 days prior to treatment initiation: Albumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 3 mg/dlXx_NEWLINE_xXAlbumin > 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXCalcium < 10.1 mg/dL (corrected to serum albumin)Xx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXDecreased serum albumin < 30 g/L (< 3 g/dL)Xx_NEWLINE_xXSerum albumin >= 2.5 g/dlXx_NEWLINE_xXSerum albumin > 3.0 g/dl within 14 days prior to registrationXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin >= 3.0 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXPatients on Part A and Part B: serum albumin >= 2 g/dLXx_NEWLINE_xXPatients on Part C with ALL: serum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXAlbumin < 2.0 g/dL or < 20 g/LXx_NEWLINE_xXAlbumin >= 2.8 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin greater than or equal to 3.0 g/dLXx_NEWLINE_xXSerum albumin > 3.0 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin must be >= 3.0 gm/dLXx_NEWLINE_xXAlbumin >= 3.0 gm/dLXx_NEWLINE_xXAlbumin within institutional normal rangeXx_NEWLINE_xXSerum albumin less than (<) 2.5 grams per deciliter (g/dL).Xx_NEWLINE_xXSerum albumin ? 3.0 g/dlXx_NEWLINE_xXSerum albumin ? 3.0 g/dlXx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXAlbumin ? 3.0 g/dLXx_NEWLINE_xXAlbumin > 3.0 g/dLXx_NEWLINE_xXSerum Albumin >3g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin >= 3 g/dLXx_NEWLINE_xXWithin 14 days prior to registration: Serum albumin >= 3.0 g/dLXx_NEWLINE_xXSubject has albumin < 3.0 g/dL (30 g/L).Xx_NEWLINE_xXSerum albumin ? 3 g/dLXx_NEWLINE_xXAlbumin < 3.0 g/dL (30 g/L) at screening;Xx_NEWLINE_xXSerum albumin >= 3 g/dLXx_NEWLINE_xXSerum albumin >= 3.0 g/dlXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXSerum albumin ? 3 g/dL.Xx_NEWLINE_xXAlbumin > 2.5 g/dLXx_NEWLINE_xXSerum albumin >= 2.5 g/dL, obtained within 14 days prior to initiation of study treatmentXx_NEWLINE_xXAlbumin ? 2.5 g/dL.Xx_NEWLINE_xXAlbumin >2.7 g/dL.Xx_NEWLINE_xXAlbumin ? 2 g/dlXx_NEWLINE_xXAlbumin >= 2.8 g/dLXx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXHas extensive metastatic tumor burden in the liver with serum albumin < 3.0 g/dLXx_NEWLINE_xXAlbumin greater than or equal to 2.8 g/dLXx_NEWLINE_xXAlbumin >= 2Xx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.8 g/dLXx_NEWLINE_xXAlbumin greater than or equal to 2.8 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL (within 14 days prior to day 1 of protocol therapy)Xx_NEWLINE_xXSerum albumin ?2.5 g/dl;Xx_NEWLINE_xXAlbumin >= 2.5 mg/dL (performed within 10 days of treatment initiation)Xx_NEWLINE_xXSerum albumin > 3.0 g/dlXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 10 days of treatment initiationXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXSerum albumin >= 2.5 g/dlXx_NEWLINE_xXAlbumin >= 2.5 g/dL (within 14 days of treatment initiation)Xx_NEWLINE_xXAlbumin < 3 g/dLXx_NEWLINE_xXWithin 72 h of initiating study treatment: Albumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, should be performed within 28 days of treatment initiation, unless otherwise indicatedXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXSerum albumin <30 g/L (3.0 g/dL)Xx_NEWLINE_xXSerum albumin > 30 g/L, or serum albumin = 30 g/L but normal prothrombin timeXx_NEWLINE_xXAlbumin < 2.8 g/dL (< 28 g/L)Xx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin <2.8Xx_NEWLINE_xXAlbumin >= 3 g/dlXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 2.8 g/dlXx_NEWLINE_xXAlbumin >= 3 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin levels < 2.5 g/dlXx_NEWLINE_xXSerum albumin ?3.0 g/dL.Xx_NEWLINE_xXAlbumin >= 2 g/dlXx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXDecreased serum albumin < 30 g/L (< 3 g/dL)Xx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin > 2.9 gm/dLXx_NEWLINE_xXAlbumin >= 3.0 g/dLXx_NEWLINE_xXAlbumin >=2.5 g/dLXx_NEWLINE_xXAlbumin > 25 g/LXx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXSerum albumin ? 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin less than (<) 2.5 grams per deciliter (g/dL)Xx_NEWLINE_xXCalcium < 10.1 mg/dL (corrected to serum albumin)Xx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSevere hypoalbuminemia (albumin < 3.0 g/dL);Xx_NEWLINE_xXAlbumin ? 3.0 mg/dL;Xx_NEWLINE_xXSerum albumin >= 2.8 g/dlXx_NEWLINE_xXSerum albumin ?3.0 gm/dL.Xx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin > 2.7 g/dL (repeat if more than 7 days before the first dose)Xx_NEWLINE_xXAlbumin >= 3 g/dlXx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXSerum albumin of > 3.0 g/dlXx_NEWLINE_xXSerum albumin must be > 2.5 g/dlXx_NEWLINE_xXAlbumin > 3.0 g/dL or > 30 g/LXx_NEWLINE_xXSerum albumin >= 3.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dL\r\n* NOTE: this applies to patient in the normal and renal dysfunction cohorts (N, R3 and R4); abnormal albumin is allowed for patients in the liver dysfunction cohortsXx_NEWLINE_xXSerum albumin >= 2.5 g/dLXx_NEWLINE_xXPatients must have a serum albumin >= 2.5 g/dL within 28 days prior to registrationXx_NEWLINE_xXAlbumin > 2 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dlXx_NEWLINE_xXSerum albumin\r\n* If cirrhosis present: part of Child Pugh requirement\r\n* If no cirrhosis: albumin should be >= 2.5 g/dlXx_NEWLINE_xXSerum albumin ? 2.0 gm/dL.Xx_NEWLINE_xXSerum albumin > 2.8 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin ?3.0 gm/dL.Xx_NEWLINE_xXAlbumin ? 2.8 g/dLXx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin < 30 g/L (3.0 g/dL)Xx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXAlbumin >= 3.0Xx_NEWLINE_xXAlbumin =< 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2 g/dLXx_NEWLINE_xXAlbumin: > 2.5 g/dLXx_NEWLINE_xXSerum albumin >= 2.8 g/dlXx_NEWLINE_xXSerum albumin <3.0 g/dL unless prothrombin time is within the normal range.Xx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dlXx_NEWLINE_xXAlbumin > 3.0 g/dlXx_NEWLINE_xXSerum albumin >= 2.8 g/dlXx_NEWLINE_xXAlbumin > 3.0 g/dlXx_NEWLINE_xXAlbumin > 3.0 g/dlXx_NEWLINE_xXAlbumin ? 2.8 g/dLXx_NEWLINE_xXAlbumin >= 2.6 g/dLXx_NEWLINE_xXAlbumin >= 3 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin < 30 g/L (3.0 g/dL) at screening.Xx_NEWLINE_xXSerum albumin ? 2.0 gm/dL.Xx_NEWLINE_xXSerum albumin > 2 g/dLXx_NEWLINE_xXAlbumin ? 3g/dLXx_NEWLINE_xXAlbumin ? 3g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dlXx_NEWLINE_xXAlbumin < 2.0 g/dL or < 20 g/LXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin less than 2 g/dLXx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXSerum albumin ? 30 g/LXx_NEWLINE_xXSerum Albumin >3.0 gm/dLXx_NEWLINE_xXRECURRENT/ PROGRESSIVE DIPG (STRATUM 1): Albumin >= 3 g/dlXx_NEWLINE_xXNON-PROGRESSED DIPG (STRATUM 2): Albumin >= 3 g/dlXx_NEWLINE_xXAlbumin >= 2.5 mg/dL within 7 days of treatment initiationXx_NEWLINE_xXSerum albumin >= 2.5 g/dlXx_NEWLINE_xXWithin 14 days prior to first study treatment: Albumin >= 3.5 g/dLXx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXAlbumin > 3.0 g/dlXx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXSerum albumin > 2 g/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin >= 2 g/dLXx_NEWLINE_xXSerum albumin > 3.0 g/dLXx_NEWLINE_xXAlbumin ? 2.5 g/dLXx_NEWLINE_xXSerum albumin <3.0 g/dL.Xx_NEWLINE_xXAlbumin >= 3.0 mg/dlXx_NEWLINE_xXSerum albumin < 3.0 gm/dL.Xx_NEWLINE_xXSerum albumin > 2 g/dLXx_NEWLINE_xXAlbumin >= 3.0 g/dLXx_NEWLINE_xXSerum albumin < 2.5 g/dLXx_NEWLINE_xXSerum albumin of >= 3.0 g/dLXx_NEWLINE_xXserum albumin ?3 g/dLXx_NEWLINE_xXSerum albumin < 2.5 g/dLXx_NEWLINE_xXSerum albumin > 2.5 g/dlXx_NEWLINE_xXSerum albumin ?3.2 g/dL in the absence of receipt of (IV) albumin within the previous 72 hours.Xx_NEWLINE_xXSerum albumin >= 2.8 g/dLXx_NEWLINE_xXSerum albumin >= 3 g/dLXx_NEWLINE_xXAlbumin >= 2 g/dLXx_NEWLINE_xXSerum albumin of >= 3.0 g/dLXx_NEWLINE_xXHistory of an allergic reaction to Human Serum AlbuminXx_NEWLINE_xXAlbumin should be >= 3Xx_NEWLINE_xXSubjects with serum calcium (corrected for albumin) ? 12 mg/dL.Xx_NEWLINE_xXPatients must have bilirubin < 1.5 mg/dL, transaminases < 2.5 X ULN, albumin > 3 gm/dL, creatinine < 2.0 mg/dL. Patients who have had albumin < 3 gm/dL boosted by an albumin infusion must be observed to maintain albumin at > 3gm dL for 30 days without an additional infusion.Xx_NEWLINE_xXSerum albumin < 3.0 g/dLXx_NEWLINE_xXSerum albumin < 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXAlbumin > 25 g/LXx_NEWLINE_xXAlbumin ? 3.0 mg/dL;Xx_NEWLINE_xXAlbumin >= 2.5 g/dL within 28 days prior to registrationXx_NEWLINE_xXSerum albumin >= 2 g/dLXx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXSerum albumin >= 3.0Xx_NEWLINE_xXAlbumin < 3.5Xx_NEWLINE_xXUrinary albumin > 1 g/dayXx_NEWLINE_xXSerum albumin < 3.0Xx_NEWLINE_xXSerum albumin =< 2.0 g/dLXx_NEWLINE_xXAlbumin < 3 gm/dLXx_NEWLINE_xXAlbumin >2.8 grams per deciliter (g/dL)Xx_NEWLINE_xXAlbumin >= 3.0 g/dL, obtained within 14 days of the first dose of study drugXx_NEWLINE_xXAlbumin >= 3 g/dLXx_NEWLINE_xXSerum albumin >= 3.0 g/dLXx_NEWLINE_xXParticipants in the dose escalation cohort must have a serum albumin of ? 3.2 g/dL at screening.Xx_NEWLINE_xXA serum albumin greater than or equal to 2.5 g/dLXx_NEWLINE_xXAlbumin > 2.8 g/dlXx_NEWLINE_xXAlbumin > 3.4Xx_NEWLINE_xXSerum calcium or albumin adjusted >= 8.0 mg/dL and =< 11.5 mg/dLXx_NEWLINE_xXAlbumin >= 3.5 mg/dLXx_NEWLINE_xXAlbumin > 2.5 g/dlXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXObtained within 28 days prior to registration: Albumin > 2.5 g/dLXx_NEWLINE_xXSerum albumin ? 3.0 g/dLXx_NEWLINE_xXAlbumin of >= 2.5 mg/dlXx_NEWLINE_xXAlbumin within 2 x ULNXx_NEWLINE_xXAlbumin of >= 2.5 g/dlXx_NEWLINE_xXPlasma albumin >= 3 g/dLXx_NEWLINE_xXPlasma albumin < 3 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dlXx_NEWLINE_xXSerum albumin > 3.0g/dLXx_NEWLINE_xXAlbumin < 3 g/dl obtained < 2 weeks prior to study enrollmentXx_NEWLINE_xXAlbumin < 3 g/dlXx_NEWLINE_xXAlbumin < 2 g/dlXx_NEWLINE_xXAlbumin < 2 g/dlXx_NEWLINE_xXSerum albumin >= 30 g/LXx_NEWLINE_xXAlbumin < 2 g/dlXx_NEWLINE_xXAlbumin < 2 g/dLXx_NEWLINE_xXAlbumin >= 3.2 g/dL (in the absence of receipt of intravenous albumin in the previous 72 hours)Xx_NEWLINE_xXSerum albumin > 2 g/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, obtained =< 30 days prior to registrationXx_NEWLINE_xXAlbumin >= 2.8 mg/dL, performed within 10 days of treatment initiationXx_NEWLINE_xXAlbumin ? 2.5 mg/dLXx_NEWLINE_xXAlbumin > 30 g/L (3.0 g/dL) at the screening visitXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXAlbumin >= 2.5 g/dLXx_NEWLINE_xXHypoalbuminemia (albumin < 3.5 g/dL)Xx_NEWLINE_xXAlbumin ? 2.5 g/dl.Xx_NEWLINE_xXserum albumin >2g/dLXx_NEWLINE_xXAlbumin >= 2.8 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dLXx_NEWLINE_xXAlbumin >= 2.5 mg/dL, performed within 10 days of protocol enrollmentXx_NEWLINE_xX